1 Epilepsy Drug Market Overview 1.1 Epilepsy Drug Product Scope 1.2 Epilepsy Drug Segment by Type 1.2.1 Global Epilepsy Drug Sales by Type (2020-2026) 1.2.2 First Generation Drugs 1.2.3 Second Generation Drugs 1.2.4 Third Generation Drugs 1.3 Epilepsy Drug Segment by Application 1.3.1 Global Epilepsy Drug Sales Comparison by Application (2020-2026) 1.3.2 Hospital 1.3.3 Research 1.4 Epilepsy Drug Market Estimates and Forecasts (2015-2026) 1.4.1 Global Epilepsy Drug Sales Growth Rate (2015-2026) 1.4.2 Global Epilepsy Drug Revenue and Growth Rate (2015-2026) 1.4.3 Global Epilepsy Drug Price Trends (2015-2026) 2 Epilepsy Drug Estimate and Forecast by Region 2.1 Global Epilepsy Drug Market Size by Region: 2015 VS 2020 VS 2026 2.2 Global Epilepsy Drug Retrospective Market Scenario by Region (2015-2020) 2.2.1 Global Epilepsy Drug Sales Market Share by Region (2015-2020) 2.2.2 Global Epilepsy Drug Revenue Market Share by Region (2015-2020) 2.3 Global Epilepsy Drug Market Estimates and Forecasts by Region (2021-2026) 2.3.1 Global Epilepsy Drug Sales Estimates and Forecasts by Region (2021-2026) 2.3.2 Global Epilepsy Drug Revenue Forecast by Region (2021-2026) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 United States Epilepsy Drug Estimates and Projections (2015-2026) 2.4.2 Europe Epilepsy Drug Estimates and Projections (2015-2026) 2.4.3 China Epilepsy Drug Estimates and Projections (2015-2026) 2.4.4 Japan Epilepsy Drug Estimates and Projections (2015-2026) 2.4.5 Southeast Asia Epilepsy Drug Estimates and Projections (2015-2026) 2.4.6 India Epilepsy Drug Estimates and Projections (2015-2026) 3 Global Epilepsy Drug Competition Landscape by Players 3.1 Global Top Epilepsy Drug Players by Sales (2015-2020) 3.2 Global Top Epilepsy Drug Players by Revenue (2015-2020) 3.3 Global Epilepsy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epilepsy Drug as of 2019) 3.4 Global Epilepsy Drug Average Price by Company (2015-2020) 3.5 Manufacturers Epilepsy Drug Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3.7 Primary Interviews with Key Epilepsy Drug Players (Opinion Leaders) 4 Global Epilepsy Drug Market Size by Type 4.1 Global Epilepsy Drug Historic Market Review by Type (2015-2020) 4.1.1 Global Epilepsy Drug Sales Market Share by Type (2015-2020) 4.1.2 Global Epilepsy Drug Revenue Market Share by Type (2015-2020) 4.1.3 Global Epilepsy Drug Price by Type (2015-2020) 4.2 Global Epilepsy Drug Market Estimates and Forecasts by Type (2021-2026) 4.2.1 Global Epilepsy Drug Sales Forecast by Type (2021-2026) 4.2.2 Global Epilepsy Drug Revenue Forecast by Type (2021-2026) 4.2.3 Global Epilepsy Drug Price Forecast by Type (2021-2026) 5 Global Epilepsy Drug Market Size by Application 5.1 Global Epilepsy Drug Historic Market Review by Application (2015-2020) 5.1.1 Global Epilepsy Drug Sales Market Share by Application (2015-2020) 5.1.2 Global Epilepsy Drug Revenue Market Share by Application (2015-2020) 5.1.3 Global Epilepsy Drug Price by Application (2015-2020) 5.2 Global Epilepsy Drug Market Estimates and Forecasts by Application (2021-2026) 5.2.1 Global Epilepsy Drug Sales Forecast by Application (2021-2026) 5.2.2 Global Epilepsy Drug Revenue Forecast by Application (2021-2026) 5.2.3 Global Epilepsy Drug Price Forecast by Application (2021-2026) 6 United States Epilepsy Drug Market Facts & Figures 6.1 United States Epilepsy Drug Sales Market Share by Company (2015-2020) 6.2 United States Epilepsy Drug Sales Market Share by Type (2015-2020) 6.3 United States Epilepsy Drug Sales Market Share by Application (2015-2020) 7 Europe Epilepsy Drug Market Facts & Figures 7.1 Europe Epilepsy Drug Sales Market Share by Company (2015-2020) 7.2 Europe Epilepsy Drug Sales Market Share by Type (2015-2020) 7.3 Europe Epilepsy Drug Sales Market Share by Application (2015-2020) 8 China Epilepsy Drug Market Facts & Figures 8.1 China Epilepsy Drug Sales Market Share by Company (2015-2020) 8.2 China Epilepsy Drug Sales Market Share by Type (2015-2020) 8.3 China Epilepsy Drug Sales Market Share by Application (2015-2020) 9 Japan Epilepsy Drug Market Facts & Figures 9.1 Japan Epilepsy Drug Sales Market Share by Company (3015-3030) 9.2 Japan Epilepsy Drug Sales Market Share by Type (2015-2020) 9.3 Japan Epilepsy Drug Sales Market Share by Application (2015-2020) 10 Southeast Asia Epilepsy Drug Market Facts & Figures 10.1 Southeast Asia Epilepsy Drug Sales Market Share by Company (2015-2020) 10.2 Southeast Asia Epilepsy Drug Sales Market Share by Type (2015-2020) 10.3 Southeast Asia Epilepsy Drug Sales Market Share by Application (2015-2020) 11 India Epilepsy Drug Market Facts & Figures 11.1 India Epilepsy Drug Sales Market Share by Company (2015-2020) 11.2 India Epilepsy Drug Sales Market Share by Type (2015-2020) 11.3 India Epilepsy Drug Sales Market Share by Application (2015-2020) 12 Company Profiles and Key Figures in Epilepsy Drug Business 12.1 Pfizer 12.1.1 Pfizer Corporation Information 12.1.2 Pfizer Business Overview 12.1.3 Pfizer Epilepsy Drug Sales, Revenue and Gross Margin (2015-2020) 12.1.4 Pfizer Epilepsy Drug Products Offered 12.1.5 Pfizer Recent Development 12.2 Eisai 12.2.1 Eisai Corporation Information 12.2.2 Eisai Business Overview 12.2.3 Eisai Epilepsy Drug Sales, Revenue and Gross Margin (2015-2020) 12.2.4 Eisai Epilepsy Drug Products Offered 12.2.5 Eisai Recent Development 12.3 Novartis 12.3.1 Novartis Corporation Information 12.3.2 Novartis Business Overview 12.3.3 Novartis Epilepsy Drug Sales, Revenue and Gross Margin (2015-2020) 12.3.4 Novartis Epilepsy Drug Products Offered 12.3.5 Novartis Recent Development 12.4 Sanofi 12.4.1 Sanofi Corporation Information 12.4.2 Sanofi Business Overview 12.4.3 Sanofi Epilepsy Drug Sales, Revenue and Gross Margin (2015-2020) 12.4.4 Sanofi Epilepsy Drug Products Offered 12.4.5 Sanofi Recent Development 12.5 Union Chimique Belge 12.5.1 Union Chimique Belge Corporation Information 12.5.2 Union Chimique Belge Business Overview 12.5.3 Union Chimique Belge Epilepsy Drug Sales, Revenue and Gross Margin (2015-2020) 12.5.4 Union Chimique Belge Epilepsy Drug Products Offered 12.5.5 Union Chimique Belge Recent Development 12.6 Abbott 12.6.1 Abbott Corporation Information 12.6.2 Abbott Business Overview 12.6.3 Abbott Epilepsy Drug Sales, Revenue and Gross Margin (2015-2020) 12.6.4 Abbott Epilepsy Drug Products Offered 12.6.5 Abbott Recent Development 12.7 GlaxoSmithKline 12.7.1 GlaxoSmithKline Corporation Information 12.7.2 GlaxoSmithKline Business Overview 12.7.3 GlaxoSmithKline Epilepsy Drug Sales, Revenue and Gross Margin (2015-2020) 12.7.4 GlaxoSmithKline Epilepsy Drug Products Offered 12.7.5 GlaxoSmithKline Recent Development 12.8 Sunovion Pharmaceuticals 12.8.1 Sunovion Pharmaceuticals Corporation Information 12.8.2 Sunovion Pharmaceuticals Business Overview 12.8.3 Sunovion Pharmaceuticals Epilepsy Drug Sales, Revenue and Gross Margin (2015-2020) 12.8.4 Sunovion Pharmaceuticals Epilepsy Drug Products Offered 12.8.5 Sunovion Pharmaceuticals Recent Development 12.9 Teva Pharmaceutical 12.9.1 Teva Pharmaceutical Corporation Information 12.9.2 Teva Pharmaceutical Business Overview 12.9.3 Teva Pharmaceutical Epilepsy Drug Sales, Revenue and Gross Margin (2015-2020) 12.9.4 Teva Pharmaceutical Epilepsy Drug Products Offered 12.9.5 Teva Pharmaceutical Recent Development 13 Epilepsy Drug Manufacturing Cost Analysis 13.1 Epilepsy Drug Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Epilepsy Drug 13.4 Epilepsy Drug Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Epilepsy Drug Distributors List 14.3 Epilepsy Drug Customers 15 Market Dynamics 15.1 Epilepsy Drug Market Trends 15.2 Epilepsy Drug Opportunities and Drivers 15.3 Epilepsy Drug Market Challenges 15.4 Epilepsy Drug Market Restraints 15.5 Porter's Five Forces Analysis 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer

List of Tables Table 1. Global Epilepsy Drug Sales (MT) Growth Rate by Type (2020-2026) (US$ Million) Table 2. Global Epilepsy Drug Sales (MT) Comparison by Application (2020-2026) (US$ Million) Table 3. Global Market Epilepsy Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026 Table 4. Global Epilepsy Drug Sales (MT) by Region (2015-2020) Table 5. Global Epilepsy Drug Sales Market Share by Region (2015-2020) Table 6. Global Epilepsy Drug Revenue (US$ Million) Market Share by Region (2015-2020)) Table 7. Global Epilepsy Drug Revenue Share by Region (2015-2020) Table 8. Global Epilepsy Drug Sales (MT) Forecast by Region (2021-2026) Table 9. Global Epilepsy Drug Sales Market Share Forecast by Region (2021-2026) Table 10. Global Epilepsy Drug Revenue (US$ Million) Forecast by Region (2021-2026) Table 11. Global Epilepsy Drug Revenue Share Forecast by Region (2021-2026) Table 12. Global Epilepsy Drug (MT) of Key Companies (2015-2020) Table 13. Global Epilepsy Drug Sales Share by Company (2015-2020) Table 14. Global Epilepsy Drug Revenue (US$ Million) by Company (2015-2020) Table 15. Global Epilepsy Drug Revenue Share by Company (2015-2020) Table 16. Global Epilepsy Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epilepsy Drug as of 2019) Table 17. Global Epilepsy Drug Average Price (USD/MT) of Key Company (2015-2020) Table 18. Manufacturers Epilepsy Drug Manufacturing Sites and Area Served Table 19. Manufacturers Epilepsy Drug Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Main Points Interviewed from Key Epilepsy Drug Players Table 22. Global Epilepsy Drug Sales (MT) by Type (2015-2020) Table 23. Global Epilepsy Drug Sales Share by Type (2015-2020) Table 24. Global Epilepsy Drug Revenue (US$ Million) Market Share by Type (2015-2020) Table 25. Global Epilepsy Drug Price (MT) by Type (2015-2020) Table 26. Global Epilepsy Drug Sales Share by Type (2021-2026) Table 27. Global Epilepsy Drug Revenue (US$ Million) Market Share by Type (2021-2026) Table 28. Global Epilepsy Drug Revenue Share by Type (2021-2026) Table 29. Global Epilepsy Drug Price (MT) by Type (2021-2026) Table 30. Global Epilepsy Drug Sales (MT) by Application (2015-2020) Table 31. Global Epilepsy Drug Sales Share by Application (2015-2020) Table 32. Global Epilepsy Drug Revenue (US$ Million) Market Share by Application (2015-2020) Table 33. Global Epilepsy Drug Price (MT) by Application (2015-2020) Table 34. Global Epilepsy Drug Sales (MT) by Application (2021-2026) Table 35. Global Epilepsy Drug Sales Share by Application (2021-2026) Table 36. Global Epilepsy Drug Revenue (US$ Million) Market Share by Application (2021-2026) Table 37. Global Epilepsy Drug Revenue Share by Application (2021-2026) Table 38. Global Epilepsy Drug Price (MT) by Application (2021-2026) Table 39. United States Epilepsy Drug Sales (MT) by Company (2015-2020) Table 40. United States Epilepsy Drug Sales Market Share by Company (2015-2020) Table 41. United States Epilepsy Drug Sales (MT) by Type (2015-2020) Table 42. United States Epilepsy Drug Sales Market Share by Type (2015-2020) Table 43. United States Epilepsy Drug Sales (MT) by Application (2015-2020) Table 44. United States Epilepsy Drug Sales Market Share by Application (2015-2020) Table 45. Europe Epilepsy Drug Sales (MT) by Company (2015-2020) Table 46. Europe Epilepsy Drug Sales Market Share by Company (2015-2020) Table 47. Europe Epilepsy Drug Sales (MT) by Type (2015-2020) Table 48. Europe Epilepsy Drug Sales Market Share by Type (2015-2020) Table 49. Europe Epilepsy Drug Sales (MT) by Application (2015-2020) Table 50. Europe Epilepsy Drug Sales Market Share by Type (2015-2020) Table 51. China Epilepsy Drug Sales (MT) by Company (2015-2020) Table 52. China Epilepsy Drug Sales Market Share by Company (2015-2020) Table 53. China Epilepsy Drug Sales (MT) by Type (2015-2020) Table 54. China Epilepsy Drug Sales Market Share by Type (2015-2020) Table 55. China Epilepsy Drug Sales (MT) by Application (2015-2020) Table 56. China Epilepsy Drug Sales Market Share by Application (2015-2020) Table 57. Japan Epilepsy Drug Sales (MT) by Company (2015-2020) Table 58. Japan Epilepsy Drug Sales Market Share by Company (2015-2020) Table 59. Japan Epilepsy Drug Sales (MT) by Type (2015-2020) Table 60. Japan Epilepsy Drug Sales Market Share by Type (2015-2020) Table 61. Japan Epilepsy Drug Sales (MT) by Application (2015-2020) Table 62. Japan Epilepsy Drug Sales Market Share by Application (2015-2020) Table 63. Southeast Asia Epilepsy Drug Sales (MT) by Company (2015-2020) Table 64. Southeast Asia Epilepsy Drug Sales Market Share by Company (2015-2020) Table 65. Southeast Asia Epilepsy Drug Sales (MT) by Type (2015-2020) Table 66. Southeast Asia Epilepsy Drug Sales Market Share by Type (2015-2020) Table 67. Southeast Asia Epilepsy Drug Sales (MT) by Type (2015-2020) Table 68. Southeast Asia Epilepsy Drug Sales Market Share by Application (2015-2020) Table 69. India Epilepsy Drug Sales (MT) by Company (2015-2020) Table 70. India Epilepsy Drug Sales Market Share by Company (2015-2020) Table 71. India Epilepsy Drug Sales (MT) by Type (2015-2020) Table 72. India Epilepsy Drug Sales Market Share by Type (2015-2020) Table 73. India Epilepsy Drug Sales (MT) by Application (2015-2020) Table 74. India Epilepsy Drug Sales Market Share by Application (2015-2020) Table 75. Pfizer Corporation Information Table 76. Pfizer Description and Business Overview Table 77. Pfizer Epilepsy Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 78. Pfizer Epilepsy Drug Product Table 79. Pfizer Recent Development Table 80. Eisai Corporation Information Table 81. Eisai Description and Business Overview Table 82. Eisai Epilepsy Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 83. Eisai Epilepsy Drug Product Table 84. Eisai Recent Development Table 85. Novartis Corporation Information Table 86. Novartis Description and Business Overview Table 87. Novartis Epilepsy Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 88. Novartis Epilepsy Drug Product Table 89. Novartis Recent Development Table 90. Sanofi Corporation Information Table 91. Sanofi Description and Business Overview Table 92. Sanofi Epilepsy Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 93. Sanofi Epilepsy Drug Product Table 94. Sanofi Recent Development Table 95. Union Chimique Belge Corporation Information Table 96. Union Chimique Belge Description and Business Overview Table 97. Union Chimique Belge Epilepsy Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 98. Union Chimique Belge Epilepsy Drug Product Table 99. Union Chimique Belge Recent Development Table 100. Abbott Corporation Information Table 101. Abbott Description and Business Overview Table 102. Abbott Epilepsy Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 103. Abbott Epilepsy Drug Product Table 104. Abbott Recent Development Table 105. GlaxoSmithKline Corporation Information Table 106. GlaxoSmithKline Description and Business Overview Table 107. GlaxoSmithKline Epilepsy Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 108. GlaxoSmithKline Epilepsy Drug Product Table 109. GlaxoSmithKline Recent Development Table 110. Sunovion Pharmaceuticals Corporation Information Table 111. Sunovion Pharmaceuticals Epilepsy Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 112. Sunovion Pharmaceuticals Description and Business Overview Table 113. Sunovion Pharmaceuticals Epilepsy Drug Product Table 114. Sunovion Pharmaceuticals Recent Development Table 115. Teva Pharmaceutical Corporation Information Table 116. Teva Pharmaceutical Epilepsy Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 117. Teva Pharmaceutical Description and Business Overview Table 118. Teva Pharmaceutical Epilepsy Drug Product Table 119. Teva Pharmaceutical Recent Development Table 120. Production Base and Market Concentration Rate of Raw Material Table 121. Key Suppliers of Raw Materials Table 122. Epilepsy Drug Distributors List Table 123. Epilepsy Drug Customers List Table 124. Epilepsy Drug Market Key Trends Table 125. Epilepsy Drug Key Opportunities and Drivers Table 126. Epilepsy Drug Market Challenges Table 127. Research Programs/Design for This Report Table 128. Key Data Information from Secondary Sources Table 129. Key Data Information from Primary Sources List of Figures Figure 1. Epilepsy Drug Product Picture Figure 2. Global Epilepsy Drug Sales Market Share by Type in 2020 & 2026 Figure 3. Type I Product Picture Figure 4. Type II Product Picture Figure 5. Global Epilepsy Drug Market Share by Application in 2020 & 2026 Figure 6. Hospital Examples Figure 7. Research Examples Figure 8. Global Epilepsy Drug Sales (MT) Growth Rate (2015-2026) Figure 9. Global Epilepsy Drug Revenue (US$ Million) Growth Rate (2015-2026) Figure 10. Global Epilepsy Drug Price Trends Growth Rate (2015-2026) (USD/MT) Figure 11. Global Epilepsy Drug Revenue Market Share by Region: 2015 VS 2020 Figure 12. Global Epilepsy Drug Revenue Market Share by Region: 2021 VS 2026 Figure 13. United States Epilepsy Drug Revenue (Million USD) Growth Rate (2015-2026) Figure 14. United States Epilepsy Drug Sales (MT) Growth Rate (2015-2026) Figure 15. Europe Epilepsy Drug Revenue (Million USD) Growth Rate (2015-2026) Figure 16. Europe Epilepsy Drug Sales (Million USD) Growth Rate (2015-2026) Figure 17. China Epilepsy Drug Revenue (Million USD) Growth Rate (2015-2026) Figure 18. China Epilepsy Drug Sales (Million USD) and Growth Rate (2015-2026) Figure 19. Japan Epilepsy Drug Revenue (Million USD) Growth Rate (2015-2026) Figure 20. Japan Epilepsy Drug Sales (Million USD) Growth Rate (2015-2026) Figure 21. Southeast Asia Epilepsy Drug Revenue (Million USD) Growth Rate (2015-2026) Figure 22. Southeast Asia Epilepsy Drug Sales (Million USD) Growth Rate (2015-2026) Figure 23. India Epilepsy Drug Revenue (Million USD) Growth Rate (2015-2026) Figure 24. India Epilepsy Drug Sales (Million USD) Growth Rate (2015-2026) Figure 25. Global 5 Largest Epilepsy Drug Players Market Share by Revenue in Epilepsy Drug 2015 & 2019 Figure 26. Epilepsy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 27. Global Epilepsy Drug Revenue Share by Type (2015-2020) Figure 28. Global Epilepsy Drug Revenue Growth Rate by Type in 2015 & 2019 Figure 29. Global Epilepsy Drug Revenue Share by Application (2015-2020) Figure 30. Global Epilepsy Drug Revenue Growth Rate by Application in 2015 & 2019 Figure 31. United States Epilepsy Drug Sales Market Share by Type in 2019 Figure 32. United States Epilepsy Drug Sales Market Share by Type in 2019 Figure 33. Europe Epilepsy Drug Sales Market Share by Company in 2019 Figure 34. Europe Epilepsy Drug Sales Market Share by Type in 2019 Figure 35. Europe Epilepsy Drug Sales Market Share by Application in 2019 Figure 36. China Epilepsy Drug Sales Market Share by Company in 2019 Figure 37. China Epilepsy Drug Sales Market Share by Type in 2019 Figure 38. China Epilepsy Drug Sales Market Share by Application in 2019 Figure 39. Japan Epilepsy Drug Sales Market Share by Company in 2019 Figure 40. Japan Epilepsy Drug Sales Market Share by Type in 2019 Figure 41. Japan Epilepsy Drug Sales Market Share by Application in 2019 Figure 42. Southeast Asia Epilepsy Drug Sales Market Share by Company in 2019 Figure 43. Southeast Asia Epilepsy Drug Sales Market Share by Type in 2019 Figure 44. Southeast Asia Epilepsy Drug Sales Market Share by Application in 2019 Figure 45. India Epilepsy Drug Sales Market Share by Company in 2019 Figure 46. India Epilepsy Drug Sales Market Share by Type in 2019 Figure 47. India Epilepsy Drug Sales Market Share by Application in 2019 Figure 48. Key Raw Materials Price Trend Figure 49. Manufacturing Cost Structure of Epilepsy Drug Figure 50. Manufacturing Process Analysis of Epilepsy Drug Figure 51. Epilepsy Drug Industrial Chain Analysis Figure 52. Channels of Distribution Figure 53. Distributors Profiles Figure 54. Porter's Five Forces Analysis Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Pfizer Eisai Novartis Sanofi Union Chimique Belge Abbott GlaxoSmithKline Sunovion Pharmaceuticals Teva Pharmaceutical